Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Driving and Alzheimer's disease: A neuropsychological screening battery for the elderly.

Crivelli L, Russo MJ, Farez MF, Bonetto M, Prado C, Calandri IL, Campos J, Cohen G, Méndez PC, Sabe LR, Allegri RF.

Dement Neuropsychol. 2019 Jul-Sep;13(3):312-320. doi: 10.1590/1980-57642018dn13-030008.

2.

High-technology augmentative communication for adults with post-stroke aphasia: a systematic review.

Russo MJ, Prodan V, Meda NN, Carcavallo L, Muracioli A, Sabe L, Bonamico L, Allegri RF, Olmos L.

Expert Rev Med Devices. 2017 May;14(5):355-370. doi: 10.1080/17434440.2017.1324291. Epub 2017 May 9. Review.

PMID:
28446056
3.

Usefulness of Discriminability and Response Bias Indices for the Evaluation of Recognition Memory in Mild Cognitive Impairment and Alzheimer Disease.

Russo MJ, Cohen G, Campos J, Martin ME, Clarens MF, Sabe L, Barcelo E, Allegri RF.

Dement Geriatr Cogn Disord. 2017;43(1-2):1-14. doi: 10.1159/000452255. Epub 2016 Nov 26.

PMID:
27889770
4.

Relevance of the serial position effect in the differential diagnosis of mild cognitive impairment, Alzheimer-type dementia, and normal ageing.

Martín ME, Sasson Y, Crivelli L, Roldán Gerschovich E, Campos JA, Calcagno ML, Leiguarda R, Sabe L, Allegri RF.

Neurologia. 2013 May;28(4):219-25. doi: 10.1016/j.nrl.2012.04.013. Epub 2012 Jun 12. English, Spanish.

5.

[Development and validation of a short battery of tests for the assessment of aphasia: 'bedside assessment of language'. Its use in a rehabilitation centre].

Sabe L, Courtis MJ, Saavedra MM, Prodan V, de Luján-Calcagno M, Melián S.

Rev Neurol. 2008 Apr 16-30;46(8):454-60. Spanish.

6.

[Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].

Sarasola D, de Luján-Calcagno M, Sabe L, Crivelli L, Torralva T, Roca M, García-Caballero A, Manes F.

Rev Neurol. 2005 Dec 16-31;41(12):717-21. Spanish.

7.

A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings.

Dorrego MF, Canevaro L, Kuzis G, Sabe L, Starkstein SE.

J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):289-95.

PMID:
12154153
8.

Neuropsychological effects of pallidotomy in patients with Parkinson's disease.

Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein S, Merello M, Starkstein S.

J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):563-4. No abstract available.

9.

Theory of mind and pragmatic abilities in dementia.

Cuerva AG, Sabe L, Kuzis G, Tiberti C, Dorrego F, Starkstein SE.

Neuropsychiatry Neuropsychol Behav Neurol. 2001 Jul-Sep;14(3):153-8.

PMID:
11513098
10.

The specificity of depressive symptoms in patients with Alzheimer's disease.

Chemerinski E, Petracca G, Sabe L, Kremer J, Starkstein SE.

Am J Psychiatry. 2001 Jan;158(1):68-72.

PMID:
11136635
11.

Impairments of social cognition and decision making in Alzheimer's disease.

Torralva T, Dorrego F, Sabe L, Chemerinski E, Starkstein SE.

Int Psychogeriatr. 2000 Sep;12(3):359-68.

PMID:
11081956
12.

Remote memory in Alzheimer's disease.

Dorrego MF, Sabe L, García Cuerva A, Kuzis G, Tiberti C, Boller F, Starkstein SE.

J Neuropsychiatry Clin Neurosci. 1999 Fall;11(4):490-7. Review.

PMID:
10570763
13.

Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia.

Kuzis G, Sabe L, Tiberti C, Merello M, Leiguarda R, Starkstein SE.

Neuropsychiatry Neuropsychol Behav Neurol. 1999 Oct;12(4):265-9.

PMID:
10527111
14.

Neuropsychological correlates of apathy and depression in patients with dementia.

Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein SE.

Neurology. 1999 Apr 22;52(7):1403-7.

PMID:
10227625
15.

A randomized, double-blind, placebo-controlled study of methylphenidate in patients with organic amnesia.

Tiberti C, Sabe L, Jason L, Leiguarda R, Starkstein S.

Eur J Neurol. 1998 May;5(3):297-299.

PMID:
10210846
16.

Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison.

Merello M, Nouzeilles MI, Kuzis G, Cammarota A, Sabe L, Betti O, Starkstein S, Leiguarda R.

Mov Disord. 1999 Jan;14(1):50-6.

PMID:
9918344
17.

Prevalence and correlates of aggressive behavior in Alzheimer's disease.

Chemerinski E, Petracca G, Tesón A, Sabe L, Leiguarda R, Starkstein SE.

J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):421-5.

PMID:
9813787
18.

Prevalence and correlates of the catastrophic reaction in Alzheimer's disease.

Tiberti C, Sabe L, Kuzis G, García Cuerva A, Leiguarda R, Starkstein SE.

Neurology. 1998 Feb;50(2):546-8.

PMID:
9484396
19.

Depression in classic versus akinetic-rigid Parkinson's disease.

Starkstein SE, Petracca G, Chemerinski E, Tesón A, Sabe L, Merello M, Leiguarda R.

Mov Disord. 1998 Jan;13(1):29-33.

PMID:
9452322
20.

Cognitive functions in major depression and Parkinson disease.

Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE.

Arch Neurol. 1997 Aug;54(8):982-6.

PMID:
9267973
21.

Prospective longitudinal study of depression and anosognosia in Alzheimer's disease.

Starkstein SE, Chemerinski E, Sabe L, Kuzis G, Petracca G, Tesón A, Leiguarda R.

Br J Psychiatry. 1997 Jul;171:47-52.

PMID:
9328494
22.

Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease.

Starkstein SE, Sabe L, Vázquez S, Di Lorenzo G, Martínez A, Petracca G, Tesón A, Chemerinski E, Leiguarda R.

J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):66-73.

23.

Anosognosia and procedural learning in Alzheimer's disease.

Starkstein SE, Sabe L, Cuerva AG, Kuzis G, Leiguarda R.

Neuropsychiatry Neuropsychol Behav Neurol. 1997 Apr;10(2):96-101.

PMID:
9150509
24.

SPECT findings in Alzheimer's disease and Parkinson's disease with dementia.

Starkstein SE, Vázquez S, Petracca G, Sabe L, Merello M, Leiguarda R.

Behav Neurol. 1997;10(4):121-7. doi: 10.3233/BEN-1997-10404.

25.

Two domains of anosognosia in Alzheimer's disease.

Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R.

J Neurol Neurosurg Psychiatry. 1996 Nov;61(5):485-90.

26.

Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.

Starkstein SE, Sabe L, Petracca G, Chemerinski E, Kuzis G, Merello M, Leiguarda R.

J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):381-7.

27.

Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease.

Starkstein SE, Sabe L, Vazquez S, Teson A, Petracca G, Chemerinski E, Di Lorenzo G, Leiguarda R.

Stroke. 1996 Mar;27(3):408-14.

PMID:
8610304
28.

The prevalence and clinical correlates of apathy and irritability in Alzheimer's disease.

Starkstein SE, Migliorelli R, Manes F, Tesón A, Petracca G, Chemerinski E, Sabe L, Leiguarda R.

Eur J Neurol. 1995 Dec;2(6):540-6. doi: 10.1111/j.1468-1331.1995.tb00171.x.

PMID:
24283780
29.

A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia.

Sabe L, Salvarezza F, García Cuerva A, Leiguarda R, Starkstein S.

Neurology. 1995 Dec;45(12):2272-4.

PMID:
8848206
30.

Dissociation between declarative and procedural learning in dementia and depression.

Sabe L, Jason L, Juejati M, Leiguarda R, Starkstein SE.

J Clin Exp Neuropsychol. 1995 Dec;17(6):841-8.

PMID:
8847390
31.

Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease.

Migliorelli R, Petracca G, Tesón A, Sabe L, Leiguarda R, Starkstein SE.

Psychol Med. 1995 May;25(3):505-13.

PMID:
7480431
32.

A single-photon emission computed tomographic study of anosognosia in Alzheimer's disease.

Starkstein SE, Vázquez S, Migliorelli R, Tesón A, Sabe L, Leiguarda R.

Arch Neurol. 1995 Apr;52(4):415-20.

PMID:
7710378
33.

Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease.

Migliorelli R, Tesón A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE.

Am J Psychiatry. 1995 Jan;152(1):37-44.

PMID:
7802118
34.

Quantified electroencephalographic correlates of neuropsychological deficits in Alzheimer's disease.

Pozzi D, Petracchi M, Sabe L, Golimstock A, García H, Starkstein S.

J Neuropsychiatry Clin Neurosci. 1995 Winter;7(1):61-7.

PMID:
7711494
35.

Anosognosia in Alzheimer's disease: a study of associated factors.

Migliorelli R, Tesón A, Sabe L, Petracca G, Petracchi M, Leiguarda R, Starkstein SE.

J Neuropsychiatry Clin Neurosci. 1995 Summer;7(3):338-44.

PMID:
7580194
36.

Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates.

Merello M, Sabe L, Teson A, Migliorelli R, Petracchi M, Leiguarda R, Starkstein S.

J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1503-9.

37.

Quantified electroencephalographic changes in Parkinson's disease with and without dementia.

Pozzi D, Petracchi M, Sabe L, Dancygier G, García H, Starkstein S.

Eur J Neurol. 1994 Nov;1(2):147-52. doi: 10.1111/j.1468-1331.1994.tb00063.x.

PMID:
24283483
38.

A SPECT study of delusions in Alzheimer's disease.

Starkstein SE, Vázquez S, Petracca G, Sabe L, Migliorelli R, Tesón A, Leiguarda R.

Neurology. 1994 Nov;44(11):2055-9.

PMID:
7969959
39.

Specificity of changes in cerebral blood flow in patients with frontal lobe dementia.

Starkstein SE, Migliorelli R, Tesón A, Sabe L, Vázquez S, Turjanski M, Robinson RG, Leiguarda R.

J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):790-6.

40.

Bromocriptine-induced dystonia in patients with aphasia and hemiparesis.

Leiguarda R, Merello M, Sabe L, Starkstein S.

Neurology. 1993 Nov;43(11):2319-22.

PMID:
8232949
41.

Sensitivity and specificity of the Mini-Mental State Exam in the diagnosis of dementia.

Sabe L, Jason L, Juejati M, Leiguarda R, Starkstein S.

Behav Neurol. 1993;6(4):207-10. doi: 10.3233/BEN-1993-6405.

42.

An open-label trial of bromocriptine in nonfluent aphasia.

Sabe L, Leiguarda R, Starkstein SE.

Neurology. 1992 Aug;42(8):1637-8. No abstract available.

PMID:
1641168

Supplemental Content

Support Center